Ultra Pharma
Ultra Pharma / Firm & Operating Standard

Practice & Operating Standard

How we structure regulatory engagements, the practitioners leading the dossiers, and the rigorous principles that define our track record in Kenya and East Africa.

01Methodology

Dossiers, deadlines, and technical depth

We work in rigorous dossiers and committed deadlines. Every engagement begins with an exhaustive gap analysis against active Pharmacy and Poisons Board CTD guidelines, followed by a time-bound filing plan.

Pre-Submission CTD Audits: Complete module-by-module compliance audit before submission fees are incurred.

Live Document Register: Transparent status tracking covering every query, document iteration, and milestone date.

Active Regulatory Representation: Direct technical liaison with committee evaluators during formal board sittings.

CTD dossier

Five modules, audited before a fee is paid

  • RegionalM1
  • SummariesM2
  • QualityM3
  • NonclinicalM4
  • ClinicalM5
Gap analysis to filing planAgainst active PPB CTD guidelines
02Principles

How we protect your timelines

The operational tenets that distinguish our advisory work from generic forwarding agencies.

No Blind Forwarding

Every regulatory query from the Pharmacy and Poisons Board is thoroughly analyzed with recommended solutions and draft responses before reaching your desk.

Accountable Named Leads

Engagements are led by qualified regulatory pharmacists with deep therapeutic category experience, not passed down to junior account handlers.

Financing & HTA Synergy

We connect market authorization directly to Social Health Authority (SHA) and BPTAP reimbursement pathways so products become commercially funded.

EAC Regional Harmonisation

Submissions are architected to leverage Kenyan approvals for mutual recognition and joint assessments across Uganda, Tanzania, and Rwanda.

Named leads with verifiable credentials, specialized therapeutic experience, and in-country regulatory accountability.

03Practitioners

The people who do the work

JK

James Kamindo

Principal contact

j.k@ultrapharma.co.ke
EO

Eric Ochieng

Quality and compliance

Lead Auditor ISO 13485 · GMP Specialist

LinkedIn
AH

Dr. Amina Hassan

Health economics

PhD Health Economics · BPTAP Advisory Expert

LinkedIn
DK

David Kamau

Market access lead

MSc Global Health Policy · SHA Engagement

LinkedIn
04Engagement

Start with a confidential dossier gap audit

Submit your active CTD files or product profiles for an objective feasibility assessment, timeline projection, and regulatory roadmap.

Initiate consultation